Patent · US Expired

Treatment of dementia and neurodegenerative diseases with intermediate doses of LHRH antagonists

US7288517B2 · kind B2 · utility

0Cited by

1References

14Claims

0Family size

Assignee

Aeterna Zentaris, Inc. · DE

Inventors

Jurgen Engel · Alzenau, DE
Rainer Voegeli · Bielefeld, DE

Key dates

Filing date	Apr 27, 2002
Grant date	Oct 30, 2007
Priority date	—
Expiry date	Sep 6, 2022

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/28
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to the treatment of dementia and neurodegenerative diseases like Alzheimer's disease with intermediate doses of LHRH antagonists which do not cause a castration. A preferred LHRH antagonist is cetrorelix.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.